Osotspa Public Company LimitedQ2 net profit up 8.9%, record gross margin 42.8%, and interim dividend approved.

Osotspa reported second-quarter net profit for fiscal 2026 of 1.1 billion baht, up 8.9% from the same period last year, while gross margin reached a record high of 42.8% on better production efficiency, cost and supply chain management, and growth in its core domestic business. As a result, first-half net profit from normal operations came to 2.257 billion baht, up 14.0% from a year earlier. Sales revenue on an adjusted basis grew 1.7%, while net profit and normalised profit grew 20.2% and 42.6% respectively. Domestic beverages grew 6.0%, driven by M-150, Lipovitan-D, C-Vitt and Peptein, while personal care grew 8.3%, led by Babi Mild and Ultra Mild by Babi Mild. International business excluding Myanmar grew 19.5%, even as the Myanmar business remained affected by restrictions on raw material import licences. The board approved an interim dividend of 0.45 baht per share, with the stock trading ex-dividend on 27 August and payment on 10 September 2026. For 2026, the company targets low-to-mid single-digit revenue growth on an adjusted basis.
Osotspa Public Company LimitedQ2 net profit up 8.9%, record gross margin 42.8%, and interim dividend approved.